| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemokines | 60 | 2021 | 956 | 8.330 |
Why?
|
| Receptors, CXCR3 | 58 | 2023 | 240 | 5.810 |
Why?
|
| Receptors, Chemokine | 54 | 2019 | 651 | 5.530 |
Why?
|
| Chemokines, CXC | 64 | 2012 | 416 | 5.140 |
Why?
|
| Chemokine CXCL10 | 77 | 2023 | 310 | 4.790 |
Why?
|
| Chemotaxis, Leukocyte | 37 | 2017 | 657 | 4.430 |
Why?
|
| Cell Movement | 63 | 2021 | 5194 | 3.260 |
Why?
|
| Receptors, Leukotriene B4 | 23 | 2017 | 93 | 3.100 |
Why?
|
| Neutrophils | 31 | 2024 | 3776 | 2.850 |
Why?
|
| Chemokines, CC | 34 | 2013 | 285 | 2.700 |
Why?
|
| Th2 Cells | 19 | 2020 | 1075 | 2.590 |
Why?
|
| Leukotriene B4 | 21 | 2018 | 281 | 2.490 |
Why?
|
| T-Lymphocytes | 50 | 2023 | 10261 | 2.420 |
Why?
|
| T-Lymphocyte Subsets | 20 | 2020 | 1811 | 2.260 |
Why?
|
| CD8-Positive T-Lymphocytes | 39 | 2021 | 4642 | 1.970 |
Why?
|
| Hypersensitivity | 16 | 2023 | 1168 | 1.950 |
Why?
|
| Th1 Cells | 13 | 2021 | 1039 | 1.750 |
Why?
|
| Immunity | 8 | 2021 | 1002 | 1.740 |
Why?
|
| Immunologic Memory | 15 | 2020 | 1375 | 1.720 |
Why?
|
| Inflammation | 49 | 2023 | 10850 | 1.690 |
Why?
|
| Receptor, Anaphylatoxin C5a | 3 | 2019 | 85 | 1.610 |
Why?
|
| Monocytes | 23 | 2021 | 2595 | 1.600 |
Why?
|
| Chemokine CXCL9 | 29 | 2020 | 137 | 1.590 |
Why?
|
| CD4-Positive T-Lymphocytes | 31 | 2024 | 4405 | 1.590 |
Why?
|
| Arthritis, Experimental | 7 | 2016 | 288 | 1.580 |
Why?
|
| Receptors, CCR7 | 7 | 2018 | 104 | 1.560 |
Why?
|
| Neutrophil Infiltration | 7 | 2020 | 394 | 1.520 |
Why?
|
| Mice | 205 | 2025 | 81819 | 1.480 |
Why?
|
| Lymph Nodes | 20 | 2021 | 3454 | 1.460 |
Why?
|
| Animals | 252 | 2025 | 168764 | 1.450 |
Why?
|
| Asthma | 31 | 2023 | 6270 | 1.450 |
Why?
|
| T-Lymphocytes, Regulatory | 12 | 2025 | 3111 | 1.410 |
Why?
|
| Eosinophils | 26 | 2013 | 945 | 1.400 |
Why?
|
| Dendritic Cells | 21 | 2021 | 2747 | 1.390 |
Why?
|
| Interferon-gamma | 46 | 2023 | 3160 | 1.380 |
Why?
|
| Receptors, CCR8 | 3 | 2018 | 28 | 1.370 |
Why?
|
| Allergens | 18 | 2023 | 1436 | 1.370 |
Why?
|
| Monocyte Chemoattractant Proteins | 13 | 2004 | 48 | 1.340 |
Why?
|
| Mice, Knockout | 86 | 2023 | 14448 | 1.340 |
Why?
|
| Complement C5a | 3 | 2019 | 98 | 1.320 |
Why?
|
| Mice, Inbred C57BL | 100 | 2023 | 22332 | 1.280 |
Why?
|
| Cytokines | 62 | 2020 | 7421 | 1.270 |
Why?
|
| Immunomodulation | 4 | 2022 | 547 | 1.250 |
Why?
|
| Receptors, CCR5 | 17 | 2016 | 491 | 1.200 |
Why?
|
| Receptors, CCR4 | 6 | 2016 | 75 | 1.200 |
Why?
|
| Chemokine CCL2 | 11 | 2019 | 602 | 1.190 |
Why?
|
| Arthritis | 4 | 2019 | 677 | 1.160 |
Why?
|
| Lung | 32 | 2020 | 10033 | 1.140 |
Why?
|
| Immunity, Innate | 21 | 2023 | 3081 | 1.130 |
Why?
|
| Disease Models, Animal | 51 | 2024 | 18293 | 1.110 |
Why?
|
| Lymphoid Tissue | 9 | 2019 | 444 | 1.090 |
Why?
|
| Malaria, Cerebral | 4 | 2019 | 137 | 1.070 |
Why?
|
| Chemotaxis | 16 | 2013 | 596 | 1.040 |
Why?
|
| Transendothelial and Transepithelial Migration | 3 | 2024 | 100 | 1.030 |
Why?
|
| Receptors, CCR2 | 11 | 2020 | 215 | 0.990 |
Why?
|
| Respiratory Hypersensitivity | 7 | 2019 | 271 | 0.990 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 11 | 2025 | 1657 | 0.940 |
Why?
|
| Bronchoalveolar Lavage Fluid | 20 | 2013 | 755 | 0.910 |
Why?
|
| Receptors, Purinergic P2 | 7 | 2006 | 149 | 0.900 |
Why?
|
| HIV-1 | 19 | 2019 | 6944 | 0.900 |
Why?
|
| Signal Transduction | 40 | 2023 | 23601 | 0.870 |
Why?
|
| Lymphocytic Choriomeningitis | 3 | 2021 | 140 | 0.840 |
Why?
|
| Leukocytes | 13 | 2020 | 2027 | 0.830 |
Why?
|
| Receptors, Lysosphingolipid | 4 | 2017 | 121 | 0.820 |
Why?
|
| Chemotactic Factors, Eosinophil | 14 | 2001 | 41 | 0.820 |
Why?
|
| Ovalbumin | 17 | 2015 | 674 | 0.810 |
Why?
|
| Adoptive Transfer | 12 | 2016 | 827 | 0.800 |
Why?
|
| Cell Adhesion | 14 | 2019 | 3089 | 0.780 |
Why?
|
| Vagina | 5 | 2017 | 848 | 0.760 |
Why?
|
| Fracture Healing | 1 | 2025 | 448 | 0.760 |
Why?
|
| Receptors, Cytokine | 10 | 2018 | 258 | 0.750 |
Why?
|
| Histamine Antagonists | 1 | 2021 | 93 | 0.740 |
Why?
|
| Ligands | 19 | 2021 | 3273 | 0.730 |
Why?
|
| Autoimmunity | 6 | 2023 | 1354 | 0.730 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2021 | 175 | 0.730 |
Why?
|
| Lymphocyte Activation | 23 | 2021 | 5501 | 0.730 |
Why?
|
| Chemokine CXCL1 | 2 | 2020 | 102 | 0.720 |
Why?
|
| Chemokine CCL1 | 3 | 2025 | 22 | 0.720 |
Why?
|
| Spleen | 8 | 2021 | 2296 | 0.720 |
Why?
|
| Integrin alpha1 | 1 | 2020 | 13 | 0.710 |
Why?
|
| Histamine | 2 | 2021 | 497 | 0.700 |
Why?
|
| Synaptotagmins | 2 | 2011 | 52 | 0.700 |
Why?
|
| Encephalitis, Viral | 1 | 2020 | 59 | 0.690 |
Why?
|
| Antigens | 12 | 2021 | 1438 | 0.690 |
Why?
|
| Chemokine CCL8 | 4 | 2018 | 17 | 0.690 |
Why?
|
| Endothelial Cells | 9 | 2019 | 3584 | 0.680 |
Why?
|
| Bronchial Hyperreactivity | 9 | 2013 | 300 | 0.670 |
Why?
|
| Chemokine CXCL11 | 15 | 2009 | 43 | 0.670 |
Why?
|
| Graft Rejection | 12 | 2013 | 4499 | 0.650 |
Why?
|
| Chemotactic Factors | 5 | 2015 | 195 | 0.610 |
Why?
|
| Receptors, Lysophosphatidic Acid | 4 | 2016 | 78 | 0.610 |
Why?
|
| Biological Factors | 1 | 2019 | 155 | 0.610 |
Why?
|
| Antigen-Presenting Cells | 3 | 2021 | 962 | 0.610 |
Why?
|
| Toll-Like Receptors | 6 | 2010 | 583 | 0.610 |
Why?
|
| Pulmonary Eosinophilia | 7 | 2011 | 78 | 0.600 |
Why?
|
| Mice, Transgenic | 32 | 2022 | 9550 | 0.590 |
Why?
|
| Immunization | 2 | 2020 | 1219 | 0.580 |
Why?
|
| Blood-Brain Barrier | 2 | 2024 | 1037 | 0.580 |
Why?
|
| HIV Infections | 18 | 2019 | 17533 | 0.570 |
Why?
|
| B-Lymphocytes | 8 | 2019 | 4778 | 0.560 |
Why?
|
| Orthomyxoviridae Infections | 5 | 2015 | 254 | 0.550 |
Why?
|
| Arteritis | 1 | 2019 | 159 | 0.550 |
Why?
|
| Mice, Inbred NOD | 13 | 2023 | 1837 | 0.540 |
Why?
|
| Killer Cells, Natural | 9 | 2010 | 2210 | 0.540 |
Why?
|
| Lectins, C-Type | 2 | 2020 | 592 | 0.540 |
Why?
|
| Endothelium, Vascular | 13 | 2017 | 4427 | 0.530 |
Why?
|
| Bronchi | 6 | 2007 | 843 | 0.530 |
Why?
|
| Receptors, Interleukin-8B | 4 | 2020 | 58 | 0.520 |
Why?
|
| Receptors, IgG | 6 | 2012 | 559 | 0.520 |
Why?
|
| Sphingosine | 4 | 2016 | 306 | 0.520 |
Why?
|
| Basophils | 4 | 2009 | 392 | 0.520 |
Why?
|
| Cells, Cultured | 41 | 2018 | 18973 | 0.510 |
Why?
|
| Chemokine CCL11 | 29 | 2011 | 127 | 0.510 |
Why?
|
| Adaptive Immunity | 3 | 2015 | 734 | 0.500 |
Why?
|
| Astrocytes | 2 | 2020 | 1345 | 0.500 |
Why?
|
| Membrane Glycoproteins | 8 | 2015 | 3690 | 0.490 |
Why?
|
| Fibroblasts | 10 | 2019 | 4159 | 0.490 |
Why?
|
| Receptors, Cell Surface | 5 | 2019 | 2817 | 0.490 |
Why?
|
| Dermatitis, Atopic | 3 | 2013 | 729 | 0.480 |
Why?
|
| Macrophages | 19 | 2019 | 5772 | 0.480 |
Why?
|
| Immunotherapy | 6 | 2021 | 4752 | 0.480 |
Why?
|
| T-Lymphocytes, Cytotoxic | 7 | 2021 | 1801 | 0.470 |
Why?
|
| Pulmonary Fibrosis | 7 | 2013 | 503 | 0.470 |
Why?
|
| Propylene Glycols | 3 | 2013 | 91 | 0.460 |
Why?
|
| Cell Proliferation | 17 | 2021 | 10429 | 0.460 |
Why?
|
| Mice, Inbred BALB C | 23 | 2017 | 6220 | 0.460 |
Why?
|
| Microglia | 5 | 2008 | 1372 | 0.460 |
Why?
|
| Immunophenotyping | 10 | 2022 | 1866 | 0.450 |
Why?
|
| Genitalia, Female | 1 | 2015 | 147 | 0.450 |
Why?
|
| Influenza, Human | 2 | 2023 | 1539 | 0.450 |
Why?
|
| Bronchiolitis Obliterans | 2 | 2006 | 221 | 0.450 |
Why?
|
| Receptors, CXCR4 | 12 | 2017 | 728 | 0.440 |
Why?
|
| Humans | 194 | 2025 | 765968 | 0.440 |
Why?
|
| Immunization, Passive | 1 | 2016 | 616 | 0.440 |
Why?
|
| Herpes Genitalis | 1 | 2015 | 148 | 0.440 |
Why?
|
| Down-Regulation | 7 | 2010 | 2927 | 0.430 |
Why?
|
| Herpesvirus 2, Human | 1 | 2015 | 191 | 0.430 |
Why?
|
| Pneumonia | 6 | 2020 | 2157 | 0.430 |
Why?
|
| STAT6 Transcription Factor | 4 | 2009 | 197 | 0.430 |
Why?
|
| Chlamydia trachomatis | 1 | 2015 | 240 | 0.420 |
Why?
|
| Interleukin-1beta | 4 | 2019 | 1028 | 0.420 |
Why?
|
| Lung Injury | 4 | 2013 | 430 | 0.420 |
Why?
|
| Receptors, Lymphocyte Homing | 4 | 2012 | 141 | 0.420 |
Why?
|
| Models, Immunological | 6 | 2012 | 517 | 0.410 |
Why?
|
| Rheumatic Diseases | 1 | 2019 | 622 | 0.410 |
Why?
|
| Mucus | 5 | 2020 | 346 | 0.400 |
Why?
|
| Interleukin-4 | 7 | 2013 | 1162 | 0.400 |
Why?
|
| Mice, SCID | 12 | 2017 | 2630 | 0.400 |
Why?
|
| Lysophospholipids | 5 | 2016 | 335 | 0.390 |
Why?
|
| STAT1 Transcription Factor | 4 | 2015 | 339 | 0.390 |
Why?
|
| Immunity, Cellular | 6 | 2016 | 1555 | 0.390 |
Why?
|
| Neoplasms | 7 | 2021 | 22340 | 0.390 |
Why?
|
| Chlamydia Infections | 1 | 2015 | 364 | 0.370 |
Why?
|
| Epithelium | 5 | 2013 | 1599 | 0.370 |
Why?
|
| Toxoplasma | 5 | 2012 | 158 | 0.370 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2011 | 82 | 0.370 |
Why?
|
| Cell Differentiation | 15 | 2025 | 11641 | 0.370 |
Why?
|
| Interleukin-23 | 1 | 2013 | 202 | 0.370 |
Why?
|
| Lung Transplantation | 3 | 2013 | 1311 | 0.370 |
Why?
|
| Aminoacyltransferases | 1 | 2011 | 52 | 0.360 |
Why?
|
| Gene Expression Regulation | 26 | 2016 | 11888 | 0.360 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2024 | 825 | 0.360 |
Why?
|
| Natural Killer T-Cells | 3 | 2011 | 319 | 0.360 |
Why?
|
| Inflammation Mediators | 7 | 2015 | 1884 | 0.350 |
Why?
|
| Skin | 12 | 2021 | 4489 | 0.340 |
Why?
|
| Virus Replication | 9 | 2016 | 2447 | 0.340 |
Why?
|
| Molecular Sequence Data | 27 | 2014 | 17594 | 0.340 |
Why?
|
| Arteriosclerosis | 4 | 2007 | 1053 | 0.340 |
Why?
|
| Interleukin-1alpha | 1 | 2010 | 88 | 0.340 |
Why?
|
| Calcium | 19 | 2018 | 5767 | 0.340 |
Why?
|
| Antibodies, Neutralizing | 3 | 2017 | 2010 | 0.340 |
Why?
|
| Islets of Langerhans Transplantation | 3 | 2004 | 746 | 0.340 |
Why?
|
| HIV Antibodies | 3 | 2016 | 1337 | 0.340 |
Why?
|
| Antirheumatic Agents | 1 | 2019 | 1365 | 0.340 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2022 | 2159 | 0.330 |
Why?
|
| RNA, Messenger | 40 | 2011 | 12768 | 0.330 |
Why?
|
| Interleukin-1 | 8 | 2023 | 1243 | 0.330 |
Why?
|
| Glycosaminoglycans | 5 | 2017 | 606 | 0.320 |
Why?
|
| Interleukin-8 | 6 | 2016 | 700 | 0.320 |
Why?
|
| Autoantibodies | 6 | 2022 | 2113 | 0.310 |
Why?
|
| Chemokine CCL19 | 3 | 2018 | 37 | 0.310 |
Why?
|
| Toxoplasmosis | 2 | 2006 | 94 | 0.310 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2004 | 820 | 0.310 |
Why?
|
| Scavenger Receptors, Class F | 2 | 2022 | 16 | 0.300 |
Why?
|
| Epithelial Cells | 9 | 2016 | 3681 | 0.300 |
Why?
|
| Receptors, Interleukin-8A | 2 | 2005 | 47 | 0.300 |
Why?
|
| Synovial Fluid | 4 | 2018 | 385 | 0.300 |
Why?
|
| Disease Transmission, Infectious | 1 | 2013 | 560 | 0.290 |
Why?
|
| Receptors, Eicosanoid | 1 | 2007 | 12 | 0.290 |
Why?
|
| Flow Cytometry | 16 | 2016 | 5881 | 0.290 |
Why?
|
| Antibodies | 6 | 2011 | 2417 | 0.290 |
Why?
|
| Autoimmune Diseases | 3 | 2018 | 2226 | 0.290 |
Why?
|
| Organ Specificity | 6 | 2015 | 1965 | 0.280 |
Why?
|
| Cell Migration Inhibition | 7 | 2013 | 97 | 0.280 |
Why?
|
| Antibodies, Blocking | 4 | 2018 | 249 | 0.280 |
Why?
|
| Antigens, CD1 | 3 | 2006 | 435 | 0.280 |
Why?
|
| Interleukin-5 | 6 | 2013 | 268 | 0.270 |
Why?
|
| Amino Acid Sequence | 22 | 2014 | 13400 | 0.270 |
Why?
|
| Endotoxins | 1 | 2009 | 516 | 0.270 |
Why?
|
| Lymphocytes | 7 | 2023 | 2599 | 0.270 |
Why?
|
| Chemokine CXCL12 | 10 | 2017 | 455 | 0.270 |
Why?
|
| Immune System | 2 | 2014 | 799 | 0.270 |
Why?
|
| Isoenzymes | 1 | 2011 | 1689 | 0.270 |
Why?
|
| Cell Line | 20 | 2013 | 15543 | 0.270 |
Why?
|
| Neovascularization, Pathologic | 5 | 2014 | 2631 | 0.270 |
Why?
|
| Vaccines | 1 | 2015 | 841 | 0.260 |
Why?
|
| Recombinant Proteins | 9 | 2006 | 6493 | 0.260 |
Why?
|
| Lung Diseases | 4 | 2013 | 1940 | 0.260 |
Why?
|
| Immunohistochemistry | 18 | 2016 | 11022 | 0.260 |
Why?
|
| Tumor Microenvironment | 4 | 2021 | 3946 | 0.260 |
Why?
|
| Transplantation Tolerance | 1 | 2011 | 640 | 0.260 |
Why?
|
| Mice, Inbred Strains | 11 | 2012 | 1770 | 0.250 |
Why?
|
| Protein Binding | 12 | 2018 | 9296 | 0.250 |
Why?
|
| Plasmodium berghei | 3 | 2019 | 161 | 0.250 |
Why?
|
| Psoriasis | 3 | 2013 | 919 | 0.250 |
Why?
|
| Trachea | 5 | 2006 | 1085 | 0.250 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2005 | 340 | 0.240 |
Why?
|
| Chemokine CCL21 | 3 | 2017 | 49 | 0.240 |
Why?
|
| Neurons | 3 | 2020 | 9525 | 0.240 |
Why?
|
| Macrophages, Peritoneal | 2 | 2003 | 243 | 0.240 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 543 | 0.240 |
Why?
|
| Phagocytosis | 5 | 2022 | 1520 | 0.240 |
Why?
|
| Interferon-beta | 3 | 2017 | 346 | 0.230 |
Why?
|
| Bronchial Diseases | 1 | 2005 | 151 | 0.230 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2017 | 548 | 0.230 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2004 | 1347 | 0.230 |
Why?
|
| Muscle, Smooth | 3 | 2016 | 931 | 0.230 |
Why?
|
| Chemokine CCL5 | 5 | 2000 | 213 | 0.230 |
Why?
|
| HLA-DR Antigens | 3 | 2005 | 608 | 0.230 |
Why?
|
| Bleomycin | 7 | 2011 | 491 | 0.230 |
Why?
|
| Vitiligo | 2 | 2016 | 96 | 0.230 |
Why?
|
| Islets of Langerhans | 3 | 2023 | 1349 | 0.220 |
Why?
|
| Eosinophilia | 5 | 1999 | 556 | 0.220 |
Why?
|
| Synovial Membrane | 3 | 2016 | 513 | 0.220 |
Why?
|
| Cloning, Molecular | 10 | 2011 | 4165 | 0.220 |
Why?
|
| Up-Regulation | 10 | 2017 | 4137 | 0.220 |
Why?
|
| Vasculitis | 2 | 2019 | 527 | 0.220 |
Why?
|
| Myeloid Cells | 1 | 2009 | 839 | 0.220 |
Why?
|
| Candida albicans | 3 | 2019 | 377 | 0.220 |
Why?
|
| Trans-Activators | 4 | 2016 | 2850 | 0.220 |
Why?
|
| Stromal Cells | 5 | 2018 | 1329 | 0.220 |
Why?
|
| Granulocytes | 1 | 2005 | 549 | 0.210 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 2 | 2024 | 265 | 0.210 |
Why?
|
| RNA Interference | 2 | 2016 | 2832 | 0.210 |
Why?
|
| Antibodies, Antinuclear | 1 | 2005 | 340 | 0.210 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2024 | 65 | 0.210 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 1210 | 0.210 |
Why?
|
| Base Sequence | 16 | 2016 | 12403 | 0.210 |
Why?
|
| Female | 73 | 2021 | 396112 | 0.210 |
Why?
|
| Transfection | 11 | 2016 | 5743 | 0.210 |
Why?
|
| Dengue Virus | 3 | 2013 | 202 | 0.210 |
Why?
|
| Dose-Response Relationship, Immunologic | 3 | 2016 | 355 | 0.210 |
Why?
|
| Antigens, CD1d | 4 | 2010 | 226 | 0.210 |
Why?
|
| Tyrosine | 2 | 2006 | 1428 | 0.200 |
Why?
|
| Arginine | 1 | 2006 | 933 | 0.200 |
Why?
|
| Herpesvirus 1, Human | 3 | 2024 | 743 | 0.200 |
Why?
|
| Flagellin | 1 | 2003 | 124 | 0.200 |
Why?
|
| Gene Expression | 12 | 2013 | 7584 | 0.200 |
Why?
|
| Permeability | 2 | 2024 | 726 | 0.200 |
Why?
|
| Antithrombin III | 1 | 2002 | 128 | 0.200 |
Why?
|
| Macrophage Inflammatory Proteins | 4 | 1998 | 121 | 0.200 |
Why?
|
| Molecular Targeted Therapy | 4 | 2019 | 2822 | 0.200 |
Why?
|
| Brain | 10 | 2018 | 27171 | 0.200 |
Why?
|
| Transplantation, Homologous | 8 | 2006 | 4860 | 0.200 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 297 | 0.190 |
Why?
|
| Immunity, Active | 1 | 2002 | 58 | 0.190 |
Why?
|
| Growth Substances | 2 | 2003 | 758 | 0.190 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 3733 | 0.190 |
Why?
|
| Receptors, CCR1 | 2 | 2012 | 30 | 0.190 |
Why?
|
| Dengue | 3 | 2013 | 257 | 0.190 |
Why?
|
| Homeostasis | 4 | 2015 | 3336 | 0.190 |
Why?
|
| Hypertension, Pulmonary | 2 | 2011 | 1604 | 0.190 |
Why?
|
| Alzheimer Disease | 4 | 2008 | 8730 | 0.190 |
Why?
|
| Respiratory System | 3 | 2016 | 559 | 0.190 |
Why?
|
| Heart Transplantation | 5 | 2004 | 3310 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 4 | 2016 | 2627 | 0.180 |
Why?
|
| Bone Marrow Cells | 5 | 2016 | 2412 | 0.180 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2013 | 379 | 0.180 |
Why?
|
| Heart | 2 | 2013 | 4414 | 0.180 |
Why?
|
| Lipopolysaccharides | 6 | 2023 | 2216 | 0.180 |
Why?
|
| Immunoglobulin E | 9 | 2006 | 1481 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2021 | 175 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 5 | 2008 | 3896 | 0.180 |
Why?
|
| Lymphocyte Subsets | 3 | 2013 | 315 | 0.180 |
Why?
|
| Receptors, CCR3 | 4 | 2006 | 61 | 0.180 |
Why?
|
| Lymphocyte Depletion | 3 | 2013 | 605 | 0.180 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2000 | 19 | 0.170 |
Why?
|
| Heparitin Sulfate | 2 | 2006 | 223 | 0.170 |
Why?
|
| Disease Susceptibility | 4 | 2022 | 1789 | 0.170 |
Why?
|
| Heparin | 3 | 2003 | 1630 | 0.170 |
Why?
|
| Spores, Fungal | 1 | 2020 | 90 | 0.170 |
Why?
|
| Pyroglyphidae | 1 | 2020 | 94 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2013 | 3807 | 0.170 |
Why?
|
| RNA, Small Interfering | 6 | 2017 | 3421 | 0.170 |
Why?
|
| Acyclovir | 1 | 2020 | 267 | 0.160 |
Why?
|
| DNA, Complementary | 7 | 2004 | 1984 | 0.160 |
Why?
|
| Receptors, Interferon | 2 | 2018 | 114 | 0.160 |
Why?
|
| Antigen Presentation | 4 | 2014 | 1250 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2016 | 2203 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2018 | 1679 | 0.160 |
Why?
|
| Antigens, Ly | 2 | 2017 | 296 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 11 | 2017 | 9249 | 0.160 |
Why?
|
| Interleukin-12 | 5 | 2021 | 579 | 0.160 |
Why?
|
| Antigens, CD | 5 | 2021 | 4025 | 0.160 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2016 | 91 | 0.160 |
Why?
|
| Peritonitis | 2 | 2003 | 369 | 0.160 |
Why?
|
| Fever | 1 | 2006 | 1603 | 0.160 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2005 | 617 | 0.160 |
Why?
|
| Receptors, Immunologic | 4 | 2015 | 1415 | 0.160 |
Why?
|
| Duffy Blood-Group System | 1 | 2019 | 60 | 0.160 |
Why?
|
| Lymphocyte Count | 5 | 2016 | 790 | 0.160 |
Why?
|
| Receptors, CCR6 | 3 | 2012 | 73 | 0.150 |
Why?
|
| Male | 61 | 2019 | 363698 | 0.150 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2019 | 1132 | 0.150 |
Why?
|
| Receptors, Scavenger | 3 | 2009 | 123 | 0.150 |
Why?
|
| Multiple Sclerosis | 2 | 2013 | 3213 | 0.150 |
Why?
|
| Melanoma, Experimental | 4 | 2016 | 558 | 0.150 |
Why?
|
| Lyme Disease | 3 | 2010 | 631 | 0.150 |
Why?
|
| Aspergillosis | 1 | 2020 | 242 | 0.150 |
Why?
|
| Epitopes | 2 | 2022 | 2523 | 0.150 |
Why?
|
| Integrin alpha Chains | 1 | 2018 | 93 | 0.150 |
Why?
|
| Transcriptional Activation | 2 | 2001 | 1744 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 12 | 2017 | 6113 | 0.150 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2009 | 89 | 0.150 |
Why?
|
| Osteogenesis | 1 | 2025 | 1282 | 0.150 |
Why?
|
| Epidermis | 3 | 2019 | 538 | 0.150 |
Why?
|
| Airway Remodeling | 1 | 2019 | 134 | 0.140 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 995 | 0.140 |
Why?
|
| Viral Load | 5 | 2013 | 3386 | 0.140 |
Why?
|
| Immunologic Surveillance | 1 | 2018 | 92 | 0.140 |
Why?
|
| Paracrine Communication | 1 | 2019 | 277 | 0.140 |
Why?
|
| Interleukins | 3 | 2015 | 791 | 0.140 |
Why?
|
| Cell Line, Transformed | 4 | 2006 | 858 | 0.140 |
Why?
|
| Platelet Activation | 1 | 2001 | 645 | 0.140 |
Why?
|
| Receptors, OX40 | 1 | 2017 | 46 | 0.140 |
Why?
|
| Neutrophil Activation | 1 | 2018 | 180 | 0.140 |
Why?
|
| Transcription, Genetic | 10 | 2020 | 7599 | 0.140 |
Why?
|
| Cerebellum | 2 | 2002 | 1518 | 0.140 |
Why?
|
| Cell Communication | 3 | 2021 | 1660 | 0.140 |
Why?
|
| Orthomyxoviridae | 2 | 2015 | 147 | 0.140 |
Why?
|
| Platelet Factor 4 | 2 | 1995 | 132 | 0.140 |
Why?
|
| Directed Molecular Evolution | 1 | 2018 | 167 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 3 | 2019 | 1995 | 0.140 |
Why?
|
| Blotting, Western | 6 | 2013 | 5020 | 0.130 |
Why?
|
| Platelet Aggregation | 1 | 2000 | 769 | 0.130 |
Why?
|
| Chemokine CCL24 | 3 | 2013 | 8 | 0.130 |
Why?
|
| Species Specificity | 5 | 2014 | 2406 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2207 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2023 | 3446 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2019 | 2060 | 0.130 |
Why?
|
| Leishmania donovani | 1 | 2016 | 68 | 0.130 |
Why?
|
| Receptors, CCR | 1 | 2016 | 37 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1599 | 0.130 |
Why?
|
| Dexamethasone | 3 | 2000 | 1963 | 0.130 |
Why?
|
| Cell Lineage | 5 | 2012 | 2573 | 0.130 |
Why?
|
| HIV | 3 | 2016 | 1585 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1892 | 0.130 |
Why?
|
| Chemokine CCL22 | 2 | 2009 | 27 | 0.130 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2016 | 99 | 0.130 |
Why?
|
| Reperfusion Injury | 3 | 2008 | 1042 | 0.130 |
Why?
|
| Chemokine CCL17 | 2 | 2009 | 25 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 852 | 0.130 |
Why?
|
| Chromosome Mapping | 6 | 1999 | 4618 | 0.120 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2015 | 55 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1997 | 416 | 0.120 |
Why?
|
| Viral Envelope Proteins | 1 | 1999 | 640 | 0.120 |
Why?
|
| Respiratory Mucosa | 3 | 2006 | 438 | 0.120 |
Why?
|
| CARD Signaling Adaptor Proteins | 3 | 2020 | 164 | 0.120 |
Why?
|
| L-Selectin | 3 | 2008 | 212 | 0.120 |
Why?
|
| Nasal Mucosa | 5 | 2006 | 416 | 0.120 |
Why?
|
| Mucous Membrane | 1 | 2019 | 657 | 0.120 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 574 | 0.120 |
Why?
|
| Liver | 6 | 2016 | 7562 | 0.120 |
Why?
|
| Myocardial Infarction | 2 | 2013 | 11499 | 0.120 |
Why?
|
| Mast Cells | 3 | 2013 | 1412 | 0.120 |
Why?
|
| Terminology as Topic | 2 | 2020 | 1534 | 0.120 |
Why?
|
| Exodeoxyribonucleases | 1 | 2016 | 191 | 0.120 |
Why?
|
| Ureteral Obstruction | 1 | 2016 | 291 | 0.120 |
Why?
|
| Proteoglycans | 1 | 1998 | 793 | 0.120 |
Why?
|
| Tomography, Optical Coherence | 3 | 2019 | 2932 | 0.120 |
Why?
|
| Protein Synthesis Inhibitors | 3 | 2000 | 187 | 0.120 |
Why?
|
| Adiponectin | 3 | 2011 | 1119 | 0.110 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 537 | 0.110 |
Why?
|
| Bone Marrow | 3 | 2016 | 2921 | 0.110 |
Why?
|
| Biological Transport | 3 | 2011 | 2081 | 0.110 |
Why?
|
| Leukocyte Count | 4 | 2016 | 1602 | 0.110 |
Why?
|
| Binding Sites | 6 | 2007 | 6001 | 0.110 |
Why?
|
| Silicon Dioxide | 1 | 2015 | 217 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2019 | 543 | 0.110 |
Why?
|
| Panniculitis | 1 | 2014 | 46 | 0.110 |
Why?
|
| Genes | 3 | 1989 | 1825 | 0.110 |
Why?
|
| Virulence Factors, Bordetella | 3 | 2002 | 152 | 0.110 |
Why?
|
| Fetus | 3 | 2002 | 1870 | 0.110 |
Why?
|
| Pertussis Toxin | 3 | 2002 | 174 | 0.110 |
Why?
|
| Macrophage Activation | 5 | 2010 | 552 | 0.110 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2015 | 169 | 0.110 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2013 | 36 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2017 | 2056 | 0.110 |
Why?
|
| Carotid Artery Diseases | 1 | 2000 | 874 | 0.110 |
Why?
|
| Phenotype | 9 | 2016 | 16721 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2002 | 1857 | 0.110 |
Why?
|
| Serine | 2 | 2014 | 824 | 0.110 |
Why?
|
| Peritoneal Fibrosis | 1 | 2013 | 9 | 0.110 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2015 | 582 | 0.100 |
Why?
|
| Integrin alpha4 | 1 | 2013 | 89 | 0.100 |
Why?
|
| Gene Knockout Techniques | 2 | 2013 | 798 | 0.100 |
Why?
|
| Antiviral Agents | 2 | 2002 | 3050 | 0.100 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2005 | 197 | 0.100 |
Why?
|
| Listeriosis | 1 | 2014 | 146 | 0.100 |
Why?
|
| Crosses, Genetic | 3 | 2015 | 752 | 0.100 |
Why?
|
| Aorta | 2 | 2019 | 2028 | 0.100 |
Why?
|
| Radiation Chimera | 1 | 2012 | 216 | 0.100 |
Why?
|
| Bronchoscopy | 3 | 2019 | 909 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 3 | 2002 | 413 | 0.100 |
Why?
|
| Pericytes | 1 | 2015 | 299 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2016 | 10729 | 0.100 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2007 | 2429 | 0.100 |
Why?
|
| Giant Cell Arteritis | 1 | 2016 | 302 | 0.100 |
Why?
|
| Lymphotoxin-alpha | 1 | 2012 | 94 | 0.100 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 145 | 0.100 |
Why?
|
| Prostaglandin D2 | 2 | 2004 | 109 | 0.100 |
Why?
|
| Leukotrienes | 1 | 2013 | 232 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2019 | 838 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2016 | 3401 | 0.100 |
Why?
|
| Immunoglobulin G | 8 | 2022 | 4528 | 0.100 |
Why?
|
| Listeria monocytogenes | 1 | 2014 | 244 | 0.100 |
Why?
|
| Apoptosis | 4 | 2013 | 9514 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 3513 | 0.100 |
Why?
|
| Transcription Factors | 5 | 2016 | 12131 | 0.100 |
Why?
|
| Stem Cells | 1 | 2025 | 3540 | 0.100 |
Why?
|
| Kinetics | 6 | 2006 | 6274 | 0.100 |
Why?
|
| Genes, vif | 1 | 2011 | 15 | 0.090 |
Why?
|
| Cervix Uteri | 2 | 2016 | 579 | 0.090 |
Why?
|
| Nephritis | 2 | 2013 | 146 | 0.090 |
Why?
|
| Acute Disease | 6 | 2005 | 7232 | 0.090 |
Why?
|
| Genes, gag | 1 | 2011 | 59 | 0.090 |
Why?
|
| Cell Division | 5 | 2004 | 4475 | 0.090 |
Why?
|
| Obesity | 3 | 2014 | 13076 | 0.090 |
Why?
|
| Pulmonary Artery | 2 | 2011 | 1935 | 0.090 |
Why?
|
| Immunity, Mucosal | 1 | 2015 | 498 | 0.090 |
Why?
|
| Kidney Diseases | 2 | 2016 | 2098 | 0.090 |
Why?
|
| Microscopy | 1 | 2016 | 901 | 0.090 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2011 | 25 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2003 | 891 | 0.090 |
Why?
|
| Thymus Gland | 4 | 2006 | 1261 | 0.090 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 139 | 0.090 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 2011 | 28 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2014 | 353 | 0.090 |
Why?
|
| Lymph | 2 | 2014 | 78 | 0.090 |
Why?
|
| Conserved Sequence | 2 | 2009 | 1160 | 0.090 |
Why?
|
| Joints | 1 | 2012 | 321 | 0.090 |
Why?
|
| CD40 Ligand | 1 | 2012 | 528 | 0.090 |
Why?
|
| Reactive Oxygen Species | 4 | 2020 | 2140 | 0.090 |
Why?
|
| Chorioretinitis | 1 | 2011 | 43 | 0.090 |
Why?
|
| Graft vs Host Disease | 4 | 2016 | 3078 | 0.090 |
Why?
|
| Receptors, CXCR | 1 | 2011 | 52 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2009 | 1499 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3608 | 0.090 |
Why?
|
| Cricetinae | 4 | 2017 | 2411 | 0.090 |
Why?
|
| Dermatitis | 1 | 2012 | 199 | 0.090 |
Why?
|
| Sequence Alignment | 3 | 2003 | 2171 | 0.090 |
Why?
|
| Blood Proteins | 3 | 2002 | 1188 | 0.090 |
Why?
|
| Intestinal Mucosa | 2 | 2002 | 3046 | 0.090 |
Why?
|
| Chemokine CCL4 | 4 | 1998 | 124 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 1118 | 0.090 |
Why?
|
| Syndecan-4 | 1 | 2010 | 44 | 0.090 |
Why?
|
| Myofibroblasts | 3 | 2019 | 229 | 0.090 |
Why?
|
| Synaptotagmin II | 1 | 2010 | 14 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2011 | 1242 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 1154 | 0.090 |
Why?
|
| Interferons | 2 | 2020 | 714 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2034 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 15880 | 0.090 |
Why?
|
| Bronchial Provocation Tests | 2 | 2019 | 217 | 0.080 |
Why?
|
| Myocardium | 2 | 2019 | 4760 | 0.080 |
Why?
|
| Clone Cells | 4 | 2003 | 1672 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 839 | 0.080 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 163 | 0.080 |
Why?
|
| RANK Ligand | 1 | 2011 | 319 | 0.080 |
Why?
|
| Egg Proteins | 2 | 2006 | 58 | 0.080 |
Why?
|
| Receptors, Leukotriene | 1 | 2010 | 97 | 0.080 |
Why?
|
| Trichuris | 1 | 2009 | 32 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2015 | 1113 | 0.080 |
Why?
|
| Hepatic Stellate Cells | 1 | 2010 | 117 | 0.080 |
Why?
|
| Chronic Disease | 4 | 2021 | 9347 | 0.080 |
Why?
|
| Blotting, Northern | 4 | 2006 | 1546 | 0.080 |
Why?
|
| Membrane Fusion | 1 | 2011 | 264 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2016 | 3222 | 0.080 |
Why?
|
| Coronary Vessels | 2 | 2019 | 3096 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 4 | 2010 | 6069 | 0.080 |
Why?
|
| Interleukin-2 | 2 | 2013 | 1896 | 0.080 |
Why?
|
| Proteins | 6 | 2013 | 5995 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2013 | 910 | 0.080 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2011 | 245 | 0.080 |
Why?
|
| Plasmids | 3 | 2004 | 2274 | 0.080 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2024 | 1441 | 0.080 |
Why?
|
| In Situ Hybridization | 4 | 2000 | 1886 | 0.080 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2010 | 298 | 0.080 |
Why?
|
| Borrelia burgdorferi | 1 | 2010 | 184 | 0.080 |
Why?
|
| Survival Rate | 3 | 2008 | 12795 | 0.080 |
Why?
|
| Lung Compliance | 1 | 2009 | 207 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2003 | 4348 | 0.080 |
Why?
|
| Transplantation Chimera | 1 | 2011 | 609 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2009 | 1211 | 0.080 |
Why?
|
| Cryptococcus neoformans | 1 | 2009 | 110 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 506 | 0.070 |
Why?
|
| Ectromelia virus | 1 | 2007 | 5 | 0.070 |
Why?
|
| Vascular Diseases | 2 | 2010 | 1159 | 0.070 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2001 | 346 | 0.070 |
Why?
|
| Calcium Signaling | 2 | 2011 | 733 | 0.070 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 1999 | 101 | 0.070 |
Why?
|
| Gene Library | 1 | 2011 | 1067 | 0.070 |
Why?
|
| Aspergillus fumigatus | 2 | 2020 | 158 | 0.070 |
Why?
|
| Antigen-Antibody Complex | 3 | 2005 | 508 | 0.070 |
Why?
|
| Receptors, HIV | 2 | 1999 | 159 | 0.070 |
Why?
|
| Interleukin-17 | 2 | 2016 | 921 | 0.070 |
Why?
|
| Airway Resistance | 1 | 2009 | 407 | 0.070 |
Why?
|
| Erythema Chronicum Migrans | 1 | 2008 | 50 | 0.070 |
Why?
|
| Acrodermatitis | 1 | 2007 | 15 | 0.070 |
Why?
|
| Borrelia | 1 | 2008 | 66 | 0.070 |
Why?
|
| Cell Membrane | 4 | 2006 | 3634 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 1102 | 0.070 |
Why?
|
| Protein Biosynthesis | 3 | 1998 | 2086 | 0.070 |
Why?
|
| Biopsy | 3 | 2016 | 6763 | 0.070 |
Why?
|
| Pseudolymphoma | 1 | 2007 | 30 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2016 | 874 | 0.070 |
Why?
|
| Antibody Formation | 2 | 2009 | 1391 | 0.070 |
Why?
|
| Chitin | 1 | 2007 | 34 | 0.070 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1987 | 58 | 0.070 |
Why?
|
| Drug Synergism | 2 | 2002 | 1749 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2007 | 34 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2011 | 346 | 0.070 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 2002 | 511 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2446 | 0.070 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 17075 | 0.070 |
Why?
|
| Keratinocytes | 4 | 2016 | 863 | 0.070 |
Why?
|
| Kidney | 3 | 2016 | 7066 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2023 | 586 | 0.070 |
Why?
|
| Wound Healing | 1 | 1998 | 2792 | 0.070 |
Why?
|
| Rabbits | 3 | 1999 | 4734 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2010 | 1644 | 0.070 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 778 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2268 | 0.070 |
Why?
|
| Intubation, Intratracheal | 2 | 2006 | 1303 | 0.070 |
Why?
|
| Intestine, Small | 2 | 2004 | 1214 | 0.070 |
Why?
|
| Histamine Release | 2 | 1996 | 119 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2010 | 903 | 0.070 |
Why?
|
| Phosphorylation | 4 | 2022 | 8278 | 0.070 |
Why?
|
| Chemokine CXCL6 | 1 | 2006 | 14 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2535 | 0.070 |
Why?
|
| Culture Media, Conditioned | 3 | 2003 | 522 | 0.070 |
Why?
|
| Hybridization, Genetic | 1 | 2006 | 102 | 0.070 |
Why?
|
| BCG Vaccine | 2 | 2000 | 380 | 0.070 |
Why?
|
| Colon | 2 | 2012 | 1795 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2004 | 812 | 0.070 |
Why?
|
| Graft vs Host Reaction | 1 | 2006 | 100 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4562 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 1999 | 2745 | 0.060 |
Why?
|
| Bronchoalveolar Lavage | 3 | 2011 | 131 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1987 | 378 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2005 | 1966 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1987 | 412 | 0.060 |
Why?
|
| Survival | 1 | 2006 | 160 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 14751 | 0.060 |
Why?
|
| Erythema | 1 | 2007 | 262 | 0.060 |
Why?
|
| Phylogeny | 1 | 2013 | 2832 | 0.060 |
Why?
|
| Aortic Rupture | 1 | 2009 | 303 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 538 | 0.060 |
Why?
|
| Interferon Type I | 2 | 2015 | 567 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2011 | 702 | 0.060 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2009 | 348 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3819 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2009 | 1144 | 0.060 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 226 | 0.060 |
Why?
|
| Granuloma | 2 | 2016 | 327 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 3 | 2009 | 2729 | 0.060 |
Why?
|
| Cycloheximide | 2 | 2000 | 339 | 0.060 |
Why?
|
| Mice, Inbred CBA | 3 | 2011 | 439 | 0.060 |
Why?
|
| West Nile Fever | 1 | 2005 | 77 | 0.060 |
Why?
|
| Peptides | 3 | 2024 | 4331 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4260 | 0.060 |
Why?
|
| West Nile virus | 1 | 2005 | 77 | 0.060 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2005 | 192 | 0.060 |
Why?
|
| Influenza A virus | 1 | 2008 | 453 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2013 | 1797 | 0.060 |
Why?
|
| Helicobacter felis | 1 | 2004 | 1 | 0.060 |
Why?
|
| Fibrosis | 4 | 2016 | 2070 | 0.060 |
Why?
|
| Growth Inhibitors | 2 | 2006 | 376 | 0.060 |
Why?
|
| Disease Progression | 4 | 2015 | 13632 | 0.060 |
Why?
|
| Receptors, Prostaglandin | 1 | 2004 | 54 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 313 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2009 | 1151 | 0.060 |
Why?
|
| Ribonucleases | 2 | 2006 | 265 | 0.060 |
Why?
|
| Transplantation, Isogeneic | 2 | 2002 | 251 | 0.060 |
Why?
|
| Spinal Cord | 2 | 2004 | 1784 | 0.060 |
Why?
|
| Klebsiella Infections | 1 | 2005 | 146 | 0.060 |
Why?
|
| CHO Cells | 2 | 1998 | 1372 | 0.060 |
Why?
|
| Peroxidases | 2 | 2002 | 134 | 0.060 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2004 | 58 | 0.060 |
Why?
|
| Food Hypersensitivity | 1 | 2012 | 737 | 0.060 |
Why?
|
| Arrestins | 1 | 2004 | 73 | 0.060 |
Why?
|
| Nucleocapsid | 1 | 2024 | 60 | 0.060 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2007 | 2587 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2016 | 5786 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4893 | 0.060 |
Why?
|
| T-Box Domain Proteins | 1 | 2006 | 469 | 0.060 |
Why?
|
| Simian immunodeficiency virus | 2 | 2019 | 812 | 0.060 |
Why?
|
| Cell Survival | 3 | 2021 | 5747 | 0.050 |
Why?
|
| Cell Polarity | 2 | 2011 | 636 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1987 | 792 | 0.050 |
Why?
|
| Receptors, Fc | 4 | 1989 | 536 | 0.050 |
Why?
|
| Klebsiella pneumoniae | 1 | 2005 | 253 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2006 | 637 | 0.050 |
Why?
|
| Dynamins | 1 | 2004 | 138 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2022 | 9525 | 0.050 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2003 | 48 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2007 | 472 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 1939 | 0.050 |
Why?
|
| Endothelium | 2 | 2004 | 767 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 461 | 0.050 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2003 | 67 | 0.050 |
Why?
|
| Decidua | 1 | 2003 | 80 | 0.050 |
Why?
|
| Phagocytes | 2 | 2022 | 292 | 0.050 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2003 | 42 | 0.050 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2003 | 218 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2022 | 1240 | 0.050 |
Why?
|
| Binding Sites, Antibody | 1 | 2003 | 340 | 0.050 |
Why?
|
| Granzymes | 2 | 2010 | 278 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2004 | 244 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2007 | 6203 | 0.050 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2003 | 98 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2005 | 591 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 2024 | 0.050 |
Why?
|
| Pneumonia, Bacterial | 1 | 2005 | 318 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2017 | 2266 | 0.050 |
Why?
|
| Murine hepatitis virus | 1 | 2002 | 18 | 0.050 |
Why?
|
| Macaca mulatta | 2 | 2019 | 2341 | 0.050 |
Why?
|
| Monokines | 2 | 1999 | 71 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2003 | 1336 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2014 | 3312 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5337 | 0.050 |
Why?
|
| Macrophages, Alveolar | 3 | 1999 | 413 | 0.050 |
Why?
|
| Encephalomyelitis | 1 | 2002 | 37 | 0.050 |
Why?
|
| Superoxides | 1 | 2003 | 383 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2006 | 1957 | 0.050 |
Why?
|
| Multigene Family | 2 | 1997 | 1080 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2006 | 1072 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2000 | 2485 | 0.050 |
Why?
|
| Time Factors | 10 | 2014 | 40065 | 0.050 |
Why?
|
| Atherosclerosis | 3 | 2009 | 3424 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 1 | 2002 | 87 | 0.050 |
Why?
|
| Cell-Free System | 2 | 1999 | 339 | 0.050 |
Why?
|
| Dermatitis, Contact | 1 | 2002 | 135 | 0.050 |
Why?
|
| Lung Neoplasms | 5 | 2015 | 13451 | 0.050 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2002 | 138 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2000 | 1061 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 8041 | 0.050 |
Why?
|
| Chemokine CCL3 | 2 | 1998 | 84 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 1987 | 1394 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 625 | 0.050 |
Why?
|
| GTP-Binding Proteins | 2 | 2003 | 945 | 0.050 |
Why?
|
| Integrins | 2 | 2003 | 840 | 0.050 |
Why?
|
| Eosinophil Peroxidase | 1 | 2000 | 22 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2021 | 238 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2022 | 189 | 0.050 |
Why?
|
| Benzylamines | 2 | 2017 | 251 | 0.050 |
Why?
|
| Heterocyclic Compounds | 2 | 2017 | 245 | 0.050 |
Why?
|
| Graft Survival | 2 | 2002 | 3890 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2004 | 390 | 0.040 |
Why?
|
| Thioglycolates | 1 | 2000 | 37 | 0.040 |
Why?
|
| Ear | 1 | 2021 | 172 | 0.040 |
Why?
|
| Microbodies | 1 | 2000 | 34 | 0.040 |
Why?
|
| Adult | 21 | 2019 | 223044 | 0.040 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 13648 | 0.040 |
Why?
|
| Regeneration | 1 | 2009 | 1517 | 0.040 |
Why?
|
| Interleukin-15 | 1 | 2021 | 186 | 0.040 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2000 | 110 | 0.040 |
Why?
|
| Lipids | 1 | 2011 | 3315 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 1889 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 679 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2004 | 676 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 3750 | 0.040 |
Why?
|
| Venules | 1 | 2000 | 162 | 0.040 |
Why?
|
| Chemokine CXCL13 | 2 | 2012 | 62 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 1959 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2007 | 2195 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2005 | 1078 | 0.040 |
Why?
|
| Myelin Proteins | 1 | 2000 | 212 | 0.040 |
Why?
|
| Penicillamine | 1 | 1999 | 59 | 0.040 |
Why?
|
| Ion Transport | 1 | 2001 | 322 | 0.040 |
Why?
|
| Interleukin-10 | 3 | 2013 | 1183 | 0.040 |
Why?
|
| Integrin alphaV | 1 | 2019 | 54 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 813 | 0.040 |
Why?
|
| Isoantigens | 1 | 2002 | 562 | 0.040 |
Why?
|
| Aerosols | 1 | 2002 | 633 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2009 | 1477 | 0.040 |
Why?
|
| Demyelinating Diseases | 1 | 2002 | 355 | 0.040 |
Why?
|
| Cornea | 1 | 2007 | 1316 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3785 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2008 | 1303 | 0.040 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2019 | 56 | 0.040 |
Why?
|
| Peptide Fragments | 3 | 2006 | 5125 | 0.040 |
Why?
|
| Ethmoid Sinusitis | 1 | 1998 | 25 | 0.040 |
Why?
|
| Myocarditis | 1 | 2006 | 802 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2003 | 772 | 0.040 |
Why?
|
| Guinea Pigs | 2 | 1998 | 1300 | 0.040 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2019 | 151 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2016 | 22223 | 0.040 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 149 | 0.040 |
Why?
|
| CpG Islands | 1 | 2003 | 1207 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2012 | 694 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2006 | 2666 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2000 | 1701 | 0.040 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2018 | 50 | 0.040 |
Why?
|
| Models, Biological | 3 | 2015 | 9443 | 0.040 |
Why?
|
| Biological Products | 1 | 1987 | 942 | 0.040 |
Why?
|
| p21-Activated Kinases | 1 | 2019 | 127 | 0.040 |
Why?
|
| Sinusitis | 2 | 1997 | 995 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2002 | 605 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2001 | 301 | 0.040 |
Why?
|
| Biotinylation | 1 | 2018 | 184 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 518 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 1602 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6942 | 0.040 |
Why?
|
| Actins | 2 | 2019 | 2056 | 0.040 |
Why?
|
| Vaccination | 2 | 2014 | 3426 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2892 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 2 | 1987 | 548 | 0.040 |
Why?
|
| Endocytosis | 1 | 2001 | 951 | 0.030 |
Why?
|
| Glycosylation | 2 | 2014 | 1100 | 0.030 |
Why?
|
| Chemokine CX3CL1 | 1 | 2017 | 60 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2004 | 1635 | 0.030 |
Why?
|
| Saphenous Vein | 1 | 2000 | 511 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 4044 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2018 | 300 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2000 | 841 | 0.030 |
Why?
|
| Collagen | 1 | 2005 | 2618 | 0.030 |
Why?
|
| Colitis | 1 | 2005 | 1239 | 0.030 |
Why?
|
| Birefringence | 1 | 2016 | 54 | 0.030 |
Why?
|
| Cell Count | 3 | 2011 | 1823 | 0.030 |
Why?
|
| Methionine | 1 | 1999 | 569 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2016 | 85 | 0.030 |
Why?
|
| Cattle | 1 | 2002 | 3801 | 0.030 |
Why?
|
| Serum Response Factor | 1 | 2016 | 78 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2018 | 1140 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 113 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 6364 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2001 | 774 | 0.030 |
Why?
|
| Muscle Relaxation | 1 | 2016 | 138 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2000 | 565 | 0.030 |
Why?
|
| Apolipoproteins E | 3 | 2007 | 1458 | 0.030 |
Why?
|
| Rats | 5 | 2012 | 23707 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2003 | 3946 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1988 | 1306 | 0.030 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2016 | 62 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2012 | 2570 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 1056 | 0.030 |
Why?
|
| Depression, Chemical | 1 | 1995 | 186 | 0.030 |
Why?
|
| Viremia | 1 | 2019 | 727 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 1999 | 717 | 0.030 |
Why?
|
| Dermatan Sulfate | 1 | 1995 | 43 | 0.030 |
Why?
|
| Muscles | 1 | 2000 | 1578 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 305 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 1899 | 0.030 |
Why?
|
| E-Selectin | 3 | 2005 | 576 | 0.030 |
Why?
|
| Mice, Mutant Strains | 3 | 2006 | 1745 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 9601 | 0.030 |
Why?
|
| HLA-B Antigens | 2 | 2012 | 329 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1995 | 220 | 0.030 |
Why?
|
| Antioxidants | 1 | 2023 | 1670 | 0.030 |
Why?
|
| Factor Xa | 1 | 1996 | 166 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 2476 | 0.030 |
Why?
|
| Surface Properties | 1 | 2018 | 1151 | 0.030 |
Why?
|
| Cell Separation | 3 | 2010 | 1718 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 430 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 1624 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1999 | 923 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2015 | 159 | 0.030 |
Why?
|
| Chimera | 1 | 2016 | 455 | 0.030 |
Why?
|
| Cholesterol | 1 | 2004 | 2898 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2015 | 10070 | 0.030 |
Why?
|
| Escherichia coli | 3 | 1996 | 4214 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1996 | 423 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 866 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 11840 | 0.030 |
Why?
|
| Plasmacytoma | 1 | 1995 | 174 | 0.030 |
Why?
|
| Transgenes | 1 | 2018 | 1015 | 0.030 |
Why?
|
| Antigens, Protozoan | 1 | 2016 | 314 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 286 | 0.030 |
Why?
|
| Crystallization | 1 | 2015 | 521 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1693 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2003 | 2058 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 2000 | 729 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2013 | 89 | 0.030 |
Why?
|
| Ticks | 1 | 2013 | 72 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1995 | 3737 | 0.030 |
Why?
|
| Tumor Necrosis Factors | 1 | 2013 | 109 | 0.030 |
Why?
|
| Cricetulus | 1 | 1995 | 805 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2000 | 916 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2016 | 615 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2013 | 128 | 0.030 |
Why?
|
| Complement C1q | 1 | 2013 | 82 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2000 | 1341 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 1998 | 532 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 1375 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2001 | 1263 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1998 | 1024 | 0.030 |
Why?
|
| Cartilage | 1 | 2016 | 798 | 0.030 |
Why?
|
| Middle Aged | 13 | 2016 | 223009 | 0.030 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2012 | 93 | 0.030 |
Why?
|
| Aedes | 1 | 2013 | 100 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 1874 | 0.020 |
Why?
|
| DNA Primers | 1 | 1997 | 2825 | 0.020 |
Why?
|
| Membrane Proteins | 4 | 2009 | 7851 | 0.020 |
Why?
|
| Injections, Subcutaneous | 2 | 2006 | 682 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 705 | 0.020 |
Why?
|
| DNA | 4 | 1997 | 7202 | 0.020 |
Why?
|
| Giant Cells | 1 | 2012 | 187 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 691 | 0.020 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2012 | 117 | 0.020 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2011 | 115 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2016 | 1206 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2003 | 474 | 0.020 |
Why?
|
| Dogs | 1 | 2016 | 3822 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1998 | 790 | 0.020 |
Why?
|
| Chlorhexidine | 1 | 2013 | 159 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2016 | 1880 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1991 | 216 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2003 | 479 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1991 | 134 | 0.020 |
Why?
|
| Mitogens | 1 | 2011 | 228 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2011 | 134 | 0.020 |
Why?
|
| Isoxazoles | 1 | 2013 | 234 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2006 | 2014 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2011 | 149 | 0.020 |
Why?
|
| RNA | 3 | 2006 | 2717 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2505 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 399 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 2009 | 1617 | 0.020 |
Why?
|
| Carbon Tetrachloride | 1 | 2010 | 73 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1993 | 498 | 0.020 |
Why?
|
| Hamartoma | 1 | 2013 | 233 | 0.020 |
Why?
|
| Chemokine CCL7 | 2 | 2001 | 30 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1999 | 2143 | 0.020 |
Why?
|
| Rhinitis | 1 | 1998 | 752 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1997 | 1365 | 0.020 |
Why?
|
| Mutation | 3 | 2004 | 30198 | 0.020 |
Why?
|
| Cats | 1 | 2011 | 972 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2014 | 995 | 0.020 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2013 | 263 | 0.020 |
Why?
|
| G1 Phase | 1 | 1991 | 403 | 0.020 |
Why?
|
| Melanoma | 2 | 2021 | 5719 | 0.020 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2010 | 111 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 2010 | 94 | 0.020 |
Why?
|
| Anilides | 1 | 2013 | 415 | 0.020 |
Why?
|
| Remission Induction | 1 | 2015 | 2411 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 65188 | 0.020 |
Why?
|
| beta-Alanine | 1 | 2010 | 83 | 0.020 |
Why?
|
| Umbilical Veins | 2 | 2000 | 421 | 0.020 |
Why?
|
| Antigens, CD34 | 2 | 2003 | 656 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 788 | 0.020 |
Why?
|
| Calorimetry | 1 | 2008 | 132 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1988 | 173 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 521 | 0.020 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2008 | 54 | 0.020 |
Why?
|
| Cryptococcosis | 1 | 2009 | 99 | 0.020 |
Why?
|
| Carrier Proteins | 2 | 2013 | 4913 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2008 | 173 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2000 | 3047 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 1917 | 0.020 |
Why?
|
| Drug Eruptions | 1 | 1991 | 335 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2013 | 1178 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2013 | 1019 | 0.020 |
Why?
|
| Galectin 3 | 1 | 2009 | 238 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 1987 | 116 | 0.020 |
Why?
|
| beta-Thromboglobulin | 1 | 1987 | 20 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8102 | 0.020 |
Why?
|
| Protozoan Proteins | 1 | 2013 | 843 | 0.020 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2013 | 550 | 0.020 |
Why?
|
| Austria | 1 | 2008 | 206 | 0.020 |
Why?
|
| Anti-HIV Agents | 2 | 2003 | 4559 | 0.020 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 6547 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2721 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1761 | 0.020 |
Why?
|
| Benzamides | 1 | 2013 | 1377 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 664 | 0.020 |
Why?
|
| Cancer Vaccines | 2 | 2005 | 1044 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 1987 | 228 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2008 | 766 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1989 | 919 | 0.020 |
Why?
|
| Genotype | 2 | 2016 | 13024 | 0.020 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1987 | 490 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 6544 | 0.020 |
Why?
|
| Microcirculation | 1 | 2011 | 1280 | 0.020 |
Why?
|
| Echocardiography | 1 | 2019 | 5045 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2006 | 227 | 0.020 |
Why?
|
| Candidiasis | 1 | 2009 | 371 | 0.020 |
Why?
|
| Lymphoma | 1 | 1995 | 1897 | 0.020 |
Why?
|
| Culicidae | 1 | 2006 | 110 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1998 | 2176 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1333 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2006 | 295 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2006 | 339 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2007 | 488 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2006 | 18071 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2017 | 1964 | 0.020 |
Why?
|
| Thiophenes | 1 | 2010 | 569 | 0.020 |
Why?
|
| Fucose | 1 | 2005 | 115 | 0.020 |
Why?
|
| Fucosyltransferases | 1 | 2005 | 118 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6309 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 612 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 1724 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 462 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2013 | 2864 | 0.010 |
Why?
|
| Histocompatibility | 1 | 2005 | 327 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 2007 | 596 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 578 | 0.010 |
Why?
|
| Coronavirus Infections | 1 | 2002 | 3100 | 0.010 |
Why?
|
| Receptors, IgE | 1 | 2006 | 374 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2006 | 964 | 0.010 |
Why?
|
| Cardiovirus Infections | 1 | 2003 | 21 | 0.010 |
Why?
|
| Retroviridae | 1 | 2006 | 847 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 636 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1987 | 1526 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1988 | 1500 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2003 | 38 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2010 | 1166 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2006 | 388 | 0.010 |
Why?
|
| Ion Channels | 1 | 2008 | 1045 | 0.010 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2003 | 23 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2003 | 105 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 59489 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2880 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2019 | 8532 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 2003 | 155 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4034 | 0.010 |
Why?
|
| Enterovirus Infections | 1 | 2003 | 74 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 2003 | 177 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2003 | 351 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 2900 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 114 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 975 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 3110 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 2002 | 51 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 610 | 0.010 |
Why?
|
| Gastritis | 1 | 2004 | 200 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 1727 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 9071 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 1999 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 884 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2002 | 83 | 0.010 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2002 | 51 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 713 | 0.010 |
Why?
|
| Young Adult | 3 | 2015 | 59889 | 0.010 |
Why?
|
| Aged | 6 | 2016 | 171117 | 0.010 |
Why?
|
| Peroxides | 1 | 2002 | 76 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2001 | 325 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2002 | 241 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2005 | 1092 | 0.010 |
Why?
|
| Dimerization | 1 | 2003 | 880 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 2001 | 244 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2004 | 602 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 1136 | 0.010 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2010 | 939 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 737 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 201 | 0.010 |
Why?
|
| Immune Sera | 1 | 2001 | 601 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1628 | 0.010 |
Why?
|
| Skull | 1 | 2005 | 811 | 0.010 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2000 | 83 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3797 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 4520 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2000 | 49 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 2002 | 726 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2001 | 209 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2475 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 20659 | 0.010 |
Why?
|
| Europe | 1 | 2007 | 3423 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5302 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2001 | 227 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 4209 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 557 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2002 | 538 | 0.010 |
Why?
|
| Vaccines, DNA | 1 | 2001 | 279 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1718 | 0.010 |
Why?
|
| RNA Stability | 1 | 2001 | 319 | 0.010 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1999 | 53 | 0.010 |
Why?
|
| Oocytes | 1 | 1984 | 1169 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1999 | 173 | 0.010 |
Why?
|
| Skin Tests | 1 | 2001 | 630 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 1816 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 1377 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 283 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 791 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4908 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 754 | 0.010 |
Why?
|
| Administration, Intravesical | 1 | 1998 | 88 | 0.010 |
Why?
|
| Bronchial Neoplasms | 1 | 1999 | 109 | 0.010 |
Why?
|
| Medulloblastoma | 1 | 2003 | 658 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 1947 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2001 | 633 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 680 | 0.010 |
Why?
|
| Chickens | 1 | 1999 | 842 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1998 | 212 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5753 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 822 | 0.010 |
Why?
|
| Lymphokines | 1 | 2000 | 911 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1998 | 405 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1999 | 704 | 0.010 |
Why?
|
| Leukemia | 1 | 2005 | 1522 | 0.010 |
Why?
|
| HIV Core Protein p24 | 1 | 1997 | 245 | 0.010 |
Why?
|
| Pancreas | 1 | 2003 | 1700 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2000 | 1524 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1997 | 304 | 0.010 |
Why?
|
| HLA-A2 Antigen | 1 | 1997 | 207 | 0.010 |
Why?
|
| Keratins | 2 | 1988 | 498 | 0.010 |
Why?
|
| Urologic Neoplasms | 1 | 2000 | 310 | 0.010 |
Why?
|
| Jejunum | 1 | 1998 | 474 | 0.010 |
Why?
|
| Chromatin | 1 | 1987 | 2980 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 26318 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 772 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2003 | 2920 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 2453 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1999 | 1828 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1985 | 2464 | 0.010 |
Why?
|
| United States | 2 | 2016 | 72903 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2004 | 2395 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1999 | 2910 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 1216 | 0.010 |
Why?
|
| Hybridomas | 1 | 1994 | 442 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1987 | 3646 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2001 | 3404 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8501 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6897 | 0.010 |
Why?
|
| Adolescent | 2 | 2010 | 88835 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 3607 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14652 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1995 | 1229 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1999 | 6322 | 0.010 |
Why?
|
| Transglutaminases | 1 | 1991 | 201 | 0.010 |
Why?
|
| Insulin | 1 | 2003 | 6599 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 5891 | 0.000 |
Why?
|
| Glioblastoma | 1 | 2003 | 3459 | 0.000 |
Why?
|
| Linear Models | 1 | 1998 | 5876 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4958 | 0.000 |
Why?
|
| Carcinoma | 1 | 1999 | 2312 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1999 | 9649 | 0.000 |
Why?
|
| Leishmaniasis | 1 | 1987 | 66 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15398 | 0.000 |
Why?
|
| Leprosy | 1 | 1987 | 125 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1999 | 12437 | 0.000 |
Why?
|
| Child | 1 | 2010 | 80564 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2004 | 41649 | 0.000 |
Why?
|
| Xenopus laevis | 1 | 1984 | 964 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36532 | 0.000 |
Why?
|